(R)-4567-Tetrahydro-26-Benzothiazolediamine - China Manufacturers, Factory, Suppliers

(R)-4567-Tetrahydro-26-Benzothiazolediamine, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

(R)-N-Despropyl Pramipexole CAS 106092-11-9 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — (R)-N-Despropyl Pramipexole CAS 106092-11-9 Pramipexole Intermediate Purity >99.0% (HPLC)
Read More

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

Top Selling Products

Related Blog
Reviews

The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...

2022.07.20 07:20:56
2022.03.07 11:05:21
2022.03.06 11:45:17
2022.02.10 05:19:18
2021.12.02 07:22:27
2021.11.01 22:40:49

(R)-4567-Tetrahydro-26-Benzothiazolediamine - China Manufacturers, Factory, Suppliers

Related Products

(R)-N-Despropyl Pramipexole CAS 106092-11-9 Pramipexole Intermediate Purity >99.0% (HPLC)

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

Top Selling Products

L-(+)-Lysine Monohydrochloride CAS 657-27-2 (H-Lys-OH·HCl) Assay 98.5~101.0% Factory High Quality

2-Methylbenzimidazole CAS 615-15-6 Purity ≥99.0% (HPLC) Factory Main Product

1-Adamantanecarboxylic Acid CAS 828-51-3 Purity >99.0% (GC)

Ethyl N-Boc-Piperidine-4-Carboxylate CAS 142851-03-4 High Purity

Isophytol CAS 505-32-8 Purity >96.0% (GC)

1-Methylpyrazole-5-Carboxylic Acid CAS 16034-46-1 Purity >98.0% (GC) (T)

4-Hydroxypiperidine CAS 5382-16-1 (4-Piperidinol) Purity >99.0% (HPLC)

Ubenimex Bestatin CAS 58970-76-6 Purity ≥99.0% (HPLC) API Factory High Purity

2-Heptadecylimidazole CAS 23328-87-2 Purity >85.0% (GC) Factory

2'-Fluoroacetophenone CAS 445-27-2 Purity >98.0% (GC)

Boc-D-Homoserine Lactone CAS 67198-86-1 Purity >99.0% (HPLC)

Letrozole CAS 112809-51-5 API Factory Aromatase Inhibitor II High Quality

The “Summit on COVID-19 Diagnostics & Treatment”

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

New COVID treatments offer hope

Paxlovid: what we know about Pfizer's Covid-19 pill

2022.07.20 07:20:56

2022.03.07 11:05:21

2022.03.06 11:45:17

2022.02.10 05:19:18

2021.12.02 07:22:27

2021.11.01 22:40:49

related search